NDC 65162-698-39 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65162-698
- Requested NDC
- 65162-698-39
- Package NDCs from labels
- 65162-698-90, 65162-698-39, 65162-698-54
- Manufacturer
- Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC
- Effective date
- 2025-05-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | 2025-05-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Gabapentin - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2023-04-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65162-698-39 | Gabapentin | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 28 | |
| 65162-698-54 | Gabapentin | 50 in 1 CARTON | SOLUTION | 50 | 28 | |
| 65162-698-90 | Gabapentin | 473 mL in 1 BOTTLE | SOLUTION | 473 | 28 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65162-698-90 | ML - Milliliter | 65162-698 | 781d1576-35f2-4340-9bb7-8435d1507cd5 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| ACESULFAME POTASSIUM | INACTIVE INGREDIENT | 23OV73Q5G9 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | INACTIVE INGREDIENT | K679OBS311 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | K679OBS311 |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 57383d2a-d2c7-bbdc-e063-6294a90ada98 | 2026-07-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | REMEDYREPACK INC. | 32169228-e85c-4dbf-8722-cd2f8e0f5d1a | 2026-07-20 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 4a95f18e-0de4-4ce1-9f97-bc2e8a5bac6a | 2026-07-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 3c585b71-5cfc-18d6-e063-6294a90a3dcf | 2026-07-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 172776c0-909e-49ce-bfe1-cf154a9458ba | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | df9c7c84-a8d9-4da8-babe-c55c9420d4e6 | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 6beed8eb-446c-4575-8dc8-b798623d92c7 | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 7ddc7d92-9076-41cf-97ed-d9f9edc80298 | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 72729513-bd34-44f5-9f62-297ed25c4442 | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | f31172a2-0ae9-49f2-b797-b26fe33f3f64 | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | b6db5ce9-bd4b-420d-88a7-df9d46144c81 | 2026-07-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 9b175f8d-7667-4bfe-8bb5-fd7441eed456 | 2026-07-08 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 4ddcdff5-8f1f-bff3-e063-6294a90a1195 | 2026-07-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Retaine CMC | CARBOXYMETHYLCELLULOSE SODIUM | OCuSOFT LLC | a3698c71-0c80-4246-be52-5e7d96f6c540 | 2026-07-06 | Warnings | K679OBS311 |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | f6ff265b-569b-4f5c-8fdb-00b7ad4aac7c | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Sun Pharmaceutical Industries, Inc. | c9a05f0c-b5f0-422c-9d67-6d0efc921a74 | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Strides Pharma Science Limited | 43b67ae3-ac6f-48f5-8788-9ead08376864 | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 9d401e54-d4f5-43ba-b898-dd08fc3c7bfa | 2026-07-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gralise | GABAPENTIN | Almatica Pharma LLC | 466273b1-c9fc-3930-c94b-aa11394d5140 | 2026-06-30 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.